In this paper we report the cloning and characterization of the erythropoietin (Epo) gene from the pufferfish, Fugu rubripes. This is the first nonmammalian Epo gene to be cloned. The Fugu Epo comprises 5 exons and 4 introns similar to the human EPO, and encodes a 185-amino acid protein that is 32% to 34% identical to Epo from various mammals. The synteny of genes at the Epo locus is conserved between the Fugu and humans. Unlike in mammals in which adult kidney is the primary Epo-producing organ, the heart is the main Epo-producing organ in adult Fugu. In addition to the heart, Fugu Epo is also expressed in the liver and brain similar to the human EPO. Interestingly, the transcripts in the Fugu brain are generated from a distal promoter and include an alternatively spliced first coding exon. No such brain-specific alternative splicing of Epo has been reported in mammals so far. Transient transfection studies in a fish hepatoma cell line (PLHC-1) and a human hepatoma cell line (HepG2) suggest that although the Fugu Epo promoter many not be hypoxia inducible, the gene may be regulated by hypoxia. (
IntroductionErythropoietin (Epo) is a glycoprotein hormone that plays a crucial role in ensuring supply of adequate oxygen to tissues by regulating the production of red blood cells. In mammals, Epo stimulates differentiation and proliferation of erythroid precursor cells in the bone marrow, in response to decreased environmental oxygen concentration or systemic oxygen deficiency caused by anemia. 1 In humans, fetal liver and adult kidney are the primary sites of EPO production. 1 In addition to these tissues, EPO is also produced in the central nervous system, bone marrow, spleen, heart, lung, ovary, testis, and breast cancer cells. [2][3][4][5][6][7] The production of Epo in the kidney, liver, and the central nervous system is greatly induced by hypoxic conditions. 8,9 The gene encoding the human EPO was first cloned in 1985 by 2 groups independently. 10,11 Since then, the Epo gene has been cloned from several mammalian species including nonhuman primates, rodents, ruminants, and felines. [12][13][14][15] The human EPO gene is transcribed from several start sites in the kidney and liver, and is thus independently regulated in these tissues. 16 Expression of the human EPO gene in transgenic mice has indicated that the cis-elements directing expression to the kidney are located between 6 kb and 14 kb upstream of the basal promoter, whereas the liver-specific elements are located in the 3Ј flanking region. 16 A 43-bp cis-element, capable of mediating the hypoxia response in the liver, also resides within the 3Ј flanking region, 120 bp downstream of the polyadenylation (polyA) signal. [16][17][18] Transient transfection studies in human hepatoma cell lines have demonstrated that the 3Ј enhancer induces 15-to 50-fold higher expression of a reporter gene in response to hypoxia.Although an "immunoreactive erythropoietin" that competes with human EPO for reaction with human EPO antibodies has been demonstrated in some teleos...